A detailed history of Korea Investment Corp transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Korea Investment Corp holds 321,335 shares of EW stock, worth $23.8 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
321,335
Previous 562,136 42.84%
Holding current value
$23.8 Million
Previous $51.9 Million 59.16%
% of portfolio
0.05%
Previous 0.13%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$59.7 - $93.78 $14.4 Million - $22.6 Million
-240,801 Reduced 42.84%
321,335 $21.2 Million
Q2 2024

Aug 13, 2024

BUY
$84.3 - $94.31 $2.57 Million - $2.87 Million
30,456 Added 5.73%
562,136 $51.9 Million
Q1 2024

May 14, 2024

BUY
$72.54 - $95.56 $1.81 Million - $2.38 Million
24,908 Added 4.92%
531,680 $50.8 Million
Q4 2023

Feb 13, 2024

BUY
$61.71 - $77.76 $11.9 Million - $15 Million
193,286 Added 61.66%
506,772 $38.6 Million
Q3 2023

Nov 13, 2023

SELL
$69.28 - $93.38 $20.8 Million - $28 Million
-300,050 Reduced 48.91%
313,486 $21.7 Million
Q2 2023

Aug 11, 2023

SELL
$81.41 - $94.33 $8.22 Million - $9.53 Million
-100,985 Reduced 14.13%
613,536 $57.9 Million
Q1 2023

May 12, 2023

BUY
$74.26 - $84.51 $8.39 Million - $9.55 Million
112,950 Added 18.78%
714,521 $59.1 Million
Q4 2022

Feb 13, 2023

BUY
$68.3 - $87.44 $13.2 Million - $16.9 Million
193,111 Added 47.28%
601,571 $44.9 Million
Q3 2022

Nov 10, 2022

SELL
$82.37 - $107.29 $13.7 Million - $17.9 Million
-166,499 Reduced 28.96%
408,460 $33.8 Million
Q2 2022

Aug 12, 2022

BUY
$86.5 - $128.27 $16.3 Million - $24.2 Million
188,759 Added 48.88%
574,959 $54.7 Million
Q1 2022

May 13, 2022

SELL
$101.96 - $128.34 $18.2 Million - $22.9 Million
-178,200 Reduced 31.57%
386,200 $45.5 Million
Q4 2021

Feb 09, 2022

SELL
$106.37 - $130.68 $54.9 Million - $67.4 Million
-516,000 Reduced 47.76%
564,400 $73.1 Million
Q3 2021

Nov 12, 2021

BUY
$102.91 - $122.75 $85.3 Million - $102 Million
828,800 Added 329.41%
1,080,400 $122 Million
Q2 2021

Aug 12, 2021

SELL
$83.84 - $104.76 $1.58 Million - $1.97 Million
-18,800 Reduced 6.95%
251,600 $26.1 Million
Q1 2021

May 13, 2021

SELL
$78.68 - $90.67 $13.9 Million - $16 Million
-176,500 Reduced 39.49%
270,400 $22.6 Million
Q4 2020

Feb 10, 2021

BUY
$71.69 - $91.23 $13.9 Million - $17.7 Million
194,000 Added 76.71%
446,900 $40.8 Million
Q3 2020

Nov 12, 2020

SELL
$67.19 - $87.44 $2.28 Million - $2.96 Million
-33,900 Reduced 11.82%
252,900 $20.2 Million
Q2 2020

Aug 12, 2020

BUY
$57.54 - $76.95 $11.3 Million - $15.1 Million
196,200 Added 216.56%
286,800 $19.8 Million
Q1 2020

May 14, 2020

SELL
$52.41 - $81.0 $327,824 - $506,655
-6,255 Reduced 6.46%
90,600 $17.1 Million
Q4 2019

Feb 11, 2020

SELL
$71.7 - $82.09 $803,040 - $919,408
-11,200 Reduced 10.37%
96,855 $22.6 Million
Q3 2019

Nov 12, 2019

BUY
$61.55 - $75.43 $1.11 Million - $1.37 Million
18,100 Added 20.12%
108,055 $23.8 Million
Q2 2019

Aug 12, 2019

SELL
$55.74 - $64.41 $1.34 Million - $1.55 Million
-24,100 Reduced 21.13%
89,955 $16.6 Million
Q1 2019

May 15, 2019

BUY
$47.89 - $64.05 $910,676 - $1.22 Million
19,016 Added 20.01%
114,055 $21.8 Million
Q4 2018

Feb 13, 2019

BUY
$46.41 - $56.94 $1.1 Million - $1.34 Million
23,600 Added 33.04%
95,039 $14.6 Million
Q3 2018

Nov 13, 2018

SELL
$45.7 - $58.03 $15.8 Million - $20.1 Million
-345,599 Reduced 82.87%
71,439 $12.4 Million
Q2 2018

Aug 13, 2018

BUY
$42.45 - $51.3 $458,460 - $554,040
10,800 Added 2.66%
417,038 $0
Q1 2018

May 09, 2018

BUY
$37.19 - $47.45 $381,383 - $486,599
10,255 Added 2.59%
406,238 $56.7 Million
Q4 2017

Feb 12, 2018

BUY
$33.79 - $39.39 $1.36 Million - $1.59 Million
40,300 Added 11.33%
395,983 $44.6 Million
Q3 2017

Oct 25, 2017

BUY
$36.29 - $38.83 $12.9 Million - $13.8 Million
355,683
355,683 $38.9 Million

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $45.8B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Korea Investment Corp Portfolio

Follow Korea Investment Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Korea Investment Corp, based on Form 13F filings with the SEC.

News

Stay updated on Korea Investment Corp with notifications on news.